tradmap

BNTX Biontech Se

$87.50 -0.76%

Data as of close

Healthcare · Biological Products, (No Diagnostic Substances)

Biontech Se (BNTX) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry. Shares last traded at $87.50, 29.4% below their 52-week high. Over the past year the stock is down 16.4%.

Market Cap
—
Shares Out
—
EPS (TTM) (per ord. share)
—
P/E (TTM)*
—
P/S Ratio
—
P/B Ratio
—
Dividend / ord. share
—
Dividend Yield
—
52-Week High
$124.00
52-Week Low
$79.50
Volume (venue)
31,829
Avg Vol (3m, venue)
68,011

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Biontech Se reports in EUR: EPS, dividends and financials are shown in EUR as filed, per ordinary share. There is no share count on file for the US listing (a depositary receipt prices at a ratio we do not source), so there is no market cap and no price ratio.

Performance

1W
+0.66%
1M
-9.71%
3M
-4.10%
6M
-11.95%
YTD
-8.08%
1Y
-16.44%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
39.20
SMA (50)
$96.66
SMA (200)
$97.01
Price vs SMA50
-9.47%
Price vs SMA200
-9.80%
ATR (14)
$2.76

Full technical analysis (26 indicators, D/W/M) →

Biological Products, (No Diagnostic Substances) peers

BNTX vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap. Data as of close

1–14 of 14
AMGNAmgen$251.7B28.786.6123.0%-0.13%
GILDGilead Sciences$211.3B—6.82-12.5%-0.23%
MRNAModerna$88.2B———-0.12%
RVMDRevolution Medicines, Inc.$40.4B———-1.58%
BIIBBiogen$36.8B105.923.573.4%-1.83%
EXELExelixis, Inc.$17.1B19.326.8535.5%+1.02%
NBIXNeurocrine Biosciences Inc$14.7B20.953.9819.0%-0.52%
HALOHalozyme Therapeutics, Inc.$14.6B35.388.8024.9%-1.50%
TECHBio-Techne$11.4B62.769.3915.0%-0.03%
RGENRepligen Corp$11.1B—13.73-1.5%-2.17%
QGENQiagen N.V.$10.9B25.705.2220.3%+0.33%
KYMRKymera Therapeutics, Inc.$10.9B———+0.68%
PCVXVaxcyte, Inc.$9.0B———-2.26%
KRYSKrystal Biotech, Inc.$8.8B38.9518.6647.9%-10.76%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in EUR) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.